COVID-19 COVID-19 Vaccine Public Health 
Bill of Health
OCTOBER 21, 2022
COVID-19 vaccines are extremely safe , and serious harms are rare. But rare does not mean the risk is zero; thus, we need a way to determine which people have plausible claims of harm from the vaccines, and we must then compensate them quickly and generously. By Dorit Reiss. Nevertheless, rare injuries do happen.
Bill of Health
JANUARY 24, 2022
Centers for Disease Control and Prevention (CDC) is failing parents by preventing off-label use of our existing COVID-19 vaccines in the under-five set. The CDC, through its vaccine provider agreements, prevents physicians and parents from pursuing off-label use of COVID-19 vaccinations in young children.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
NOVEMBER 8, 2022
In June 2022, after almost two years of debate over a potential COVID-19 vaccine patent waiver, the World Trade Organization adopted the Ministerial Decision on the TRIPS Agreement (“WTO Decision”), which provided for a partial waiver of intellectual property rights. appeared first on Bill of Health. By Sarah Gabriele.
Bill of Health
JANUARY 12, 2023
Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Interestingly, as of January 12, 2023, Moderna has listed 10 patents covering Spikevax (its mRNA vaccine) on its website.
Healthcare It News
OCTOBER 22, 2021
As communities across the nation seek new ways to bring COVID-19 vaccination rates up to levels that can more effectively mitigate the spread of variants, they are looking for new and better ways to reach those who are just hesitant, undecided or unaware of how to get vaccinated. Ninety-seven percent of adults in the U.S.
Healthcare Dive
DECEMBER 13, 2022
The vaccines also reduced infections and hospitalizations, which freed up hospital resources, researchers at the Commonwealth Fund and Yale School of Public Health concluded.
Bill of Health
OCTOBER 11, 2022
Since the first days of the COVID-19 pandemic, employers, businesses, and other entities have anticipated litigation around tort claims associated with the novel coronavirus. Some respondents analyze how we got here — the specific conditions of the COVID-19 pandemic that have influenced and constrained potential litigation.
Expert insights. Personalized for you.
363 
Let's personalize your content